title: Correlation between metabolic enzyme GSTP1 polymorphisms and susceptibility to lung cancer.
abstract: The aim of the present study was to determine the frequency distribution and characteristics of polymorphic alleles and genotypes in glutathioneS-transferase π 1 (GSTP1) exon 5, and to explore the correlation between GSTP1 exon 5 polymorphisms and susceptibility to lung cancer using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Patients were diagnosed with lung cancer from May 2006 to October 2008 by postoperative pathological examination. A total of 150 patients, including 115 males and 35 females, aged 31-76 years (mean, 57.1 years) were enrolled. The control group consisted of 152 healthy volunteers who received physical examination at outpatient clinics. Genomic DNA was extracted from the peripheral venous blood of the 302 subjects, and the GSTP1 genotype was determined by PCR-RFLP and restricted enzyme digestion of PCR products. GSTP1 polymorphisms were analyzed in the 302 subjects. The C and G allele frequencies of GSTP1 in the control and lung cancer groups showed no significant difference (P=0.135); the frequencies of three different genotypes, A/A, A/G and G/G, of GSTP1 in the control and lung cancer groups exhibited no significant differences between the two groups (P=0.223). GSTP1 genotype frequencies in the study population fitted the Hardy-Weinberg equilibrium, demonstrating that the genotype results of this study conform to this genetic law. Overall, 50.7% of the subjects in the lung cancer group carried the non-A/A genotype of GSTP1, which was higher than the 43.4% of the control group. The risk of lung cancer in subjects with the non-A/A genotype was 1.43-fold higher than that in those with the A/A genotype, but no statistical significance was found (P=0.138). GSTP1 exon 5 polymorphisms were demonstrated to be associated with lung cancer susceptibility on the whole. However, stratified analysis suggested the correlation of GSTP1 exon 5 polymorphisms with lung squamous cell carcinoma risk, and that exon 5 polymorphisms might increase the risk of lung squamous cell carcinoma. Exon 5 GSTP1 polymorphisms were not found to be a strong influencing factor in lung cancer risk, but may play a certain role.
authors.affiliation: Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010059, P.R. China.
authors.forename: Yufei
authors.initials: Y
authors.lastname: Wang
authors.affiliation: Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010059, P.R. China.
authors.forename: B U
authors.initials: BU
authors.lastname: Ren
authors.affiliation: Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010059, P.R. China.
authors.forename: Lei
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Department of Thoracic Surgery, The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Inner Mongolia 010059, P.R. China.
authors.forename: Zhanlin
authors.initials: Z
authors.lastname: Guo
keywords: Chinese Han population; GSTP1; lung cancer; polymorphisms